Bretylium and dobutamine in the treatment of coronary artery disease.
作者信息
Frishman W H
出版信息
Bull N Y Acad Med. 1979 Sep;55(8):798-809.
Abstract
摘要
相似文献
1
Bretylium and dobutamine in the treatment of coronary artery disease.
Bull N Y Acad Med. 1979 Sep;55(8):798-809.
2
Successful long-term suppression of previously refractory paroxysmal ventricular tachycardia with bretylium tosylate.
Heart Lung. 1979 Jul-Aug;8(4):721-7.
3
[Treatment of refractory ventricular tachycardia and fibrillation by bretylium tosylate: a report of 4 cases].
Zhonghua Xin Xue Guan Bing Za Zhi. 1987 Aug;15(4):203-4, 12.
4
Bretylium (Bretylol) for ventricular arrhythmias.
Med Lett Drugs Ther. 1978 Dec 1;20(24):105-6.
5
Bretylium tosylate: a review.
Am J Hosp Pharm. 1979 Sep;36(9):1189-92.
6
Pharmacologic reversal of hypotensive effect complicating antiarrhythmic therapy with bretylium.
Clin Pharmacol Ther. 1982 Sep;32(3):313-21. doi: 10.1038/clpt.1982.166.
7
Life threatening ventricular dysrhythmias: intervention with bretylium tosylate.
AANA J. 1983 Jun;51(3):284-9.
8
[The use of ornid in emergency cardiology (a review of the literature)].
Vrach Delo. 1988 Sep(9):37-41.
9
Experimental and clinical pharmacology of bretylium tosylate in acute myocardial infarction: a 15-year journey.
J Pharmacol. 1986 Jul-Sep;17(3):223-43.
10
[Clinical experiences with bretylium tosylate].
Z Gesamte Inn Med. 1976 Sep 1;31(17):684-8.
本文引用的文献
1
Quantitiative comparison of bretylium with other antifibrillatory drugs.
Am J Cardiol. 1968 Apr;21(4):504-12. doi: 10.1016/0002-9149(68)90282-8.
2
Bretylium tosylate in the management of refractory ventricular fibrillation.
Can Med Assoc J. 1971 Jul 24;105(2):161-5 passim.
3
Evaluation of lidocaine resistance in man using intermittent large-dose infusion techniques.
Am J Cardiol. 1974 Sep;34(3):342-9. doi: 10.1016/0002-9149(74)90037-x.
4
Chemical ventricular defibrillation of the human heart with bretylium tosylate.
Am J Cardiol. 1973 Dec;32(7):982-7. doi: 10.1016/s0002-9149(73)80168-7.
5
Effectiveness of bretylium tosylate against refractory ventricular arrhythmias.
Circulation. 1972 May;45(5):1024-34. doi: 10.1161/01.cir.45.5.1024.
6
Clinical cardiovascular pharmacology of dobutamine. A selective inotropic catecholamine.
Lancet. 1974 Aug 17;2(7877):363-7. doi: 10.1016/s0140-6736(74)91754-1.
7
Response of resistant ventricular tachycardia to bretylium. Relation to site of ectopic focus and location of myocardial disease.
Circulation. 1973 Feb;47(2):331-40. doi: 10.1161/01.cir.47.2.331.
8
Dobutamine for inotropic support during emergence from cardiopulmonary bypass.
Anesthesiology. 1976 Apr;44(4):281-6. doi: 10.1097/00000542-197604000-00001.
9
Hemodynamic effect of dobutamine in patients with severe heart failure.
Am J Cardiol. 1975 Aug;36(2):202-5. doi: 10.1016/0002-9149(75)90526-3.
10
Haemodynamic effects of a new inotropic agent (dobutamine) in chronic cardiac failure.
Br Heart J. 1975 Jun;37(6):629-34. doi: 10.1136/hrt.37.6.629.
Zotero 插件